MCCORMICK & CO INC·4

Feb 10, 2:10 PM ET

MANGAN MICHAEL D 4

4 · MCCORMICK & CO INC · Filed Feb 10, 2026

Research Summary

AI-generated summary of this filing

Updated

McCormick (MKC) Director Michael Mangan Exercises Options, Sells Shares

What Happened

  • Michael D. Mangan, a director of McCormick & Co. (MKC), exercised options and conducted a related sale on Feb 9, 2026. The filing shows he exercised option-related rights covering shares and ended up acquiring 5,000 shares (recorded at $49.96 each, total $249,800) and disposed of 5,000 shares in an open-market sale at $67.92 each for $339,600. A separate derivative line shows 5,000 shares disposed at $0, which reflects option/derivative settlement as part of the exercise process.
  • This is effectively a cashless-style exercise combined with a sale: options were exercised and some resulting shares were sold to cover costs/taxes while 5,000 shares were retained. The sale is a routine disposition; the exercise is not a market-directional purchase.

Key Details

  • Transaction date: 2026-02-09 (reported on Form 4 filed 2026-02-10 — filed promptly)
  • Open-market sale: 5,000 shares @ $67.92 = $339,600
  • Exercise/Acquisition: 5,000 shares @ $49.96 = $249,800
  • Derivative disposition: 5,000 shares @ $0 (reflects option settlement/surrender)
  • Footnote: F1 — Options exercised; no purchase price required.
  • Shares owned after transaction: Not specified in the provided summary (not reported here).

Context

  • For retail investors: this looks like a typical options exercise paired with a sell-to-cover or cashless exercise — the insider exercised option rights and sold a portion of the resulting shares while retaining others. Such transactions are common and do not by themselves indicate a change in company outlook.

Insider Transaction Report

Form 4
Period: 2026-02-09
Transactions
  • Exercise/Conversion

    Common Stock - Voting

    2026-02-09$49.96/sh+5,000$249,80048,029 total
  • Sale

    Common Stock - Voting

    2026-02-09$67.92/sh5,000$339,60043,029 total
  • Exercise/Conversion

    Options - Right to Buy

    [F1]
    2026-02-095,0000 total
    Exercise: $49.96From: 2017-03-30Exp: 2026-03-29Common Stock - Voting (5,000 underlying)
Holdings
  • Common Stock - Non Voting

    4,234
Footnotes (1)
  • [F1]Options exercised; no purchase price required.
Signature
Jason E. Wynn, Attorney-in-Fact|2026-02-10

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES